UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Using the 'dispersion-retention-formulation method' to estimate clinical and preclinical dosage limits for interstitial nanomedicines or agents

Southern, P; Pankhurst, QA; (2019) Using the 'dispersion-retention-formulation method' to estimate clinical and preclinical dosage limits for interstitial nanomedicines or agents. Journal of Magnetism and Magnetic Materials , 473 pp. 74-78. 10.1016/j.jmmm.2018.10.019. Green open access

[thumbnail of 2019 JMMM DRF Method.pdf]
Preview
Text
2019 JMMM DRF Method.pdf - Published Version

Download (585kB) | Preview

Abstract

We propose the “DRF method” for estimating dosage limits for interstitially administered therapeutic or diagnostic nanomedicines or agents from three characteristic parameters that can be experimentally determined from in vivo data. These are: (i) the dispersion of the injected fluid around the injection site; (ii) the retention of the injected fluid at the injection site; and (iii) the formulation characteristics of the fluid with respect to local and systemic tolerability. We present formulae that allow dose-limit estimates to be made for any preclinical model, as well as for clinical studies. We illustrate the DRF method for the case of iron-oxide-based magnetic fluids, with reference to the published dose limits of regulatory-body-approved magnetic nanoparticles for MRI contrast enhancement, sentinel node detection, iron replacement therapy, and magnetic thermoablation.

Type: Article
Title: Using the 'dispersion-retention-formulation method' to estimate clinical and preclinical dosage limits for interstitial nanomedicines or agents
Location: Copenhagen, DENMARK
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.jmmm.2018.10.019
Publisher version: https://doi.org/10.1016/j.jmmm.2018.10.019
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Nanomedicines, Magnetic fluids, Magnetic nanoparticles, Interstitial administration
UCL classification: UCL
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Med Phys and Biomedical Eng
URI: https://discovery.ucl.ac.uk/id/eprint/10071251
Downloads since deposit
Loading...
128Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
Loading...

Archive Staff Only

View Item View Item